GPX2 and neoplasm: In contrast, Gpx-2 protein showed a marked decrease in immunohistochemical expression, with 16 (72.73%), 7 (10.94%) and 1 (2.56%) tumours showing low levels of expression in G1, G2 and G3, respectively.